Development of a novel near-infrared fluorescent probe based on nile blue for the detection of leucine aminopeptidase as a cancer biomarker
Source abstract
Abstract
We report herein the design and synthesis of a near-infrared fluorescent probe ( NB–SO 3 -Leu ) derived from the Nile Blue (NB) fluorophore scaffold, modified with sulfonic groups to improve solubility and biocompatibility. The mechanism of action of the NB-SO 3 -Leu probe was successfully validated in the presence of leucine aminopeptidase (LAP), a widely known cancer biomarker. The fluorescence signal of NB-SO 3 -Leu , which was initially low, increased 4-fold after incubation with the LAP enzyme after 15 min. In addition, the NB-SO 3 -Leu probe was validated in vitro in 4T1 (mouse mammary carcinoma cells), HeLa (human cervical cancer cells), and SK-Mel-103 (human melanoma cells) with high endogenous LAP levels. This work aims to advance in the development of a new generation of reliable and sensitive cancer detection methods. • NB-SO 3 -Leu detects leucine aminopeptidase with a 4-fold fluorescence emission increase. • Sulfonic groups added to NB-SO 3 -Leu improve solubility and reduce toxicity. • The probe shows a nanomolar limit of detection (7.2 ng·mL −1 ), ensuring high sensitivity. • NB-SO 3 -Leu was validated successfully in cancer cell lines with high endogenous LAP concentrations. • NB-SO 3 fluorophore is a modular tool for monitoring cancer-related enzyme activity.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (67)
Show source-provided references
1. Photoacoustic imaging as a tool to probe the tumour microenvironment10.1242/dmm.039636 ↗
2. The future of early cancer detection10.1038/s41591-022-01746-x ↗
3. Application of nanomaterials in biomedical imaging and cancer therapy10.3390/nano10091700 ↗
4. The translational status of cancer liquid biopsies10.1007/s40883-019-00141-2 ↗
5. Health effects of ionising radiation from diagnostic CT10.1016/S0140-6736(06)68748-5 ↗
6. The risks of radiation exposure related to diagnostic imaging and how to minimise them10.1136/bmj.d947 ↗
7. New strategies for fluorescent probe design in medical diagnostic imaging10.1021/cr900263j ↗
8. Hanash S M, Baik C S, Kallioniemi O. Emerging molecular biomarkers—Blood-based strategies to detect and monitor cancer. Nat Rev Clin Oncol 20211; 8:142-150. https://doi.org/10.1038/nrclinonc.2010.220.10.1038/nrclinonc.2010.220 ↗
9. Cancer biomarker detection: recent achievements and challenges10.1039/C4CS00370E ↗
10. Biomarkers as biomedical bioindicators: approaches and techniques for the detection, analysis, and validation of novel biomarkers of diseases10.3390/pharmaceutics15061630 ↗
11. A NIR fluorescent probe for the detection of renal damage based on overrepresentation of alanine aminopeptidase enzyme
12. A two-photon probe based on naphthalimide-styrene fluorophore for the In Vivo tracking of cellular senescence10.1021/acs.analchem.0c05447 ↗
13. Molecular biomarkers in cancer10.3390/biom12081021 ↗
14. New biomarkers in cancers10.3390/cancers13040708 ↗
15. Tumor‐microenvironment‐responsive nanomedicine for enhanced cancer immunotherapy10.1002/advs.202103836 ↗
16. Detection and elimination of senescent cells with a self-assembled senescence-associated β-Galactosidase-Activatable nanophotosensitizer10.1021/acs.jmedchem.3c01306 ↗
17. Chemical strategies for the detection and elimination of senescent cells10.1021/acs.accounts.3c00794 ↗
18. Lipofuscin labeling through biorthogonal strain‐promoted azide‐alkyne cycloaddition for the detection of senescent cells10.1111/febs.16477 ↗
19. β‐Galactosidase‐Triggered photodynamic elimination of senescent cells with a boron dipyrromethene‐based photosensitizer10.1002/advs.202401012 ↗
20. BODIPY dyes and their derivatives: syntheses and spectroscopic properties10.1021/cr078381n ↗
21. Fluorescent labeling of biomolecules with organic probes10.1021/cr0783840 ↗
22. A selective turn-on fluorescent sensor for imaging copper in living cells10.1021/ja055064u ↗
23. Research progress of near-infrared fluorescence probes based on indole heptamethine cyanine dyes In Vivo and In Vitro10.1186/s13065-020-00677-3 ↗
24. Cyanine-based fluorescent probe for cyanide ion detection10.1007/s10895-021-02771-8 ↗
25. Coumarin-based near-infrared fluorogenic probes: recent advances, challenges and future perspectives10.1016/j.ccr.2023.215020 ↗
26. Activatable and self-monitoring hydrogen sulfide-based molecular senomorphics for visualized regulation of cellular senescence10.31635/ccschem.023.202302714 ↗
27. Design, synthesis and application in analytical chemistry of photo-sensitive probes based on coumarin
28. A comprehensive review: versatile imaging probe based on chemical materials for biomedical applications
29. Application of nanomaterials in biomedical imaging and cancer therapy10.3390/nano10091700 ↗
30. Renal‐clearable molecular semiconductor for second near‐infrared fluorescence imaging of kidney dysfunction10.1002/anie.201909560 ↗
31. Zwitterionic AIEgens: rational molecular design for NIR‐II fluorescence imaging‐guided synergistic phototherapy
32. Zwitterionic biomaterials10.1021/acs.chemrev.2c00344 ↗
33. Recent developments in the detection of bovine serum albumin10.1016/j.ijbiomac.2019.07.096 ↗
34. Development and application of cationic nile blue probes in live-cell super-resolution imaging and specific targeting to mitochondria. ACS central science10.1021/acscentsci.4c00073 ↗
35. A renal clearable fluorogenic probe for In Vivo β-galactosidase activity detection during aging and senolysis10.1038/s41467-024-44903-1 ↗
36. Real‐time in vivo detection of cellular senescence through the controlled release of the NIR fluorescent dye nile blue10.1002/anie.202004142 ↗
37. Molecular imaging and disease theranostics with renal-clearable optical agents10.1038/s41578-021-00328-6 ↗
38. Renal-clearable probes for disease detection and monitoring
39. Aminopeptidases in cancer, biology and prospects for pharmacological intervention10.2174/1568009622666220623112605 ↗
40. Aminopeptidase expression in multiple myeloma associates with disease progression and sensitivity to Melflufen10.3390/cancers13071527 ↗
41. β-Galactosidase-activatable nile blue-based NIR senoprobe for the real-time detection of cellular senescence
42. A leucine aminopeptidase activatable photosensitizer for cancer cell selective photodynamic therapy action10.1016/j.dyepig.2021.109735 ↗
43. AIE-Active lysosome-targeted fluorescent organic nanoparticles for leucine aminopeptidase-activatable fluorescent imaging and precision photodynamic therapy potential10.1016/j.dyepig.2023.111781 ↗
44. Activatable fluorescence and bio/chemiluminescence probes for aminopeptidases: from design to biomedical applications10.1002/adma.202409893 ↗
45. Research progress of small molecule fluorescent probes for liver cancer related enzymes10.1016/j.dyepig.2023.111631 ↗
46. Recent advances in enzyme-activated NIR fluorescent probes for biological applications10.1016/j.trac.2023.117335 ↗
47. Fluorescent probes for detection and bioimaging of leucine aminopeptidase
48. Recent progress of activity-based fluorescent probes for imaging leucine aminopeptidase10.3390/bios13070752 ↗
49. Leucine aminopeptidases: diversity in structure and function10.1515/BC.2006.191 ↗
50. The Most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity10.1021/jm030795v ↗
51. Biochemical and enzymatic properties of the M1 family of aminopeptidases involved in the regulation of blood pressure10.1007/s10741-007-9064-8 ↗
52. A novel role for placental leucine aminopeptidase (P‐LAP) as a determinant of chemoresistance in endometrial carcinoma cells10.1002/ijc.21509 ↗
53. A fluorescent probe for early detection of melanoma and its metastasis by specifically imaging tyrosinase activity in a mouse model10.1021/acs.analchem.8b00594 ↗
54. Hemicyanine‐based near‐infrared activatable probes for imaging and diagnosis of diseases10.1002/ange.202107877 ↗
55. Small-molecule probe using dual signals to monitor leucine aminopeptidase activity10.1016/j.bmcl.2011.02.068 ↗
56. Leucine aminopeptidase May contribute to the intrinsic resistance of cancer cells toward cisplatin as revealed by an ultrasensitive fluorescent probe10.1039/C5SC03600C ↗
57. A ratiometric fluorescent probe for monitoring leucine aminopeptidase in living cells and zebrafish model10.1021/acs.analchem.7b02910 ↗
58. Oligo (ethylene glycol)-functionalized squaraine fluorophore as a near-infrared-fluorescent probe for the In Vivo detection of diagnostic enzymes10.1021/acs.analchem.8b01968 ↗
59. Diagnosing drug-induced liver injury by multispectral optoacoustic tomography and fluorescence imaging using a leucine-aminopeptidase-activated probe10.1021/acs.analchem.9b00107 ↗
60. A highly selective and sensitive chemiluminescent probe for leucine aminopeptidase detection in vitro, in vivo and in human liver cancer tissue10.1039/D1SC06528A ↗
61. Enhancing the selectivity of leucine aminopeptidase near-infrared fluorescent probes for assisting in surgical tumor resection10.1021/acs.analchem.2c04587 ↗
62. Engineering a highly selective leucine aminopeptidase near-infrared fluorescence probe for early diagnosis of diabetic nephropathy10.1016/j.snb.2023.135127 ↗
63. Recent progresses in small-molecule enzymatic fluorescent probes for cancer imaging10.1039/C7CS00862G ↗
64. Enzyme kinetics
65. Monitoring inflammation-cancer progression by cell viscosity, polarity and leucine aminopeptidase using multicolor fluorescent probe10.1016/j.cej.2022.135043 ↗
66. Bufadienolides preferentially inhibit aminopeptidase N among Mammalian metallo-aminopeptidases; relationship with effects on human melanoma MeWo cells10.1016/j.ijbiomac.2022.12.280 ↗
67. Multi-dimensional imaging of endogenous leucine aminopeptidase via fast response fluorescent read-out probe10.1016/j.dyepig.2021.109145 ↗